Article Details

ABK Biomedical: $35 Million Series D Secured For Advancing Clinical Development Of ...

Retrieved on: 2025-10-15 16:41:33

Tags for this article:

Click the tags to see associated articles and topics

ABK Biomedical: $35 Million Series D Secured For Advancing Clinical Development Of .... View article details on hiswai:

Excerpt

ABK Biomedical, a medical device company specializing in advanced imageable embolic technologies, has raised an oversubscribed $35 million in its ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo